These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 22882148

  • 1. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas.
    Tsai JH, Huang WC, Kuo KT, Yuan RH, Chen YL, Jeng YM.
    Histopathology; 2012 Dec; 61(6):1106-16. PubMed ID: 22882148
    [Abstract] [Full Text] [Related]

  • 2. Different roles of S100P overexpression in intrahepatic cholangiocarcinoma: carcinogenesis of perihilar type and aggressive behavior of peripheral type.
    Aishima S, Fujita N, Mano Y, Kubo Y, Tanaka Y, Taketomi A, Shirabe K, Maehara Y, Oda Y.
    Am J Surg Pathol; 2011 Apr; 35(4):590-8. PubMed ID: 21412073
    [Abstract] [Full Text] [Related]

  • 3. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma.
    Higashi M, Yonezawa S, Ho JJ, Tanaka S, Irimura T, Kim YS, Sato E.
    Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510
    [Abstract] [Full Text] [Related]

  • 4. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features.
    Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM.
    Mod Pathol; 2014 Aug; 27(8):1163-73. PubMed ID: 24406866
    [Abstract] [Full Text] [Related]

  • 5. Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type.
    Aishima S, Oda Y.
    J Hepatobiliary Pancreat Sci; 2015 Feb; 22(2):94-100. PubMed ID: 25181580
    [Abstract] [Full Text] [Related]

  • 6. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
    Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-Hensch N, Kristiansen G, Jochum W.
    Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
    [Abstract] [Full Text] [Related]

  • 7. Comparison of the Clinicopathological Features in Small Bile Duct and Bile Ductular Type Intrahepatic Cholangiocarcinoma.
    Yamada M, Yamamoto Y, Sugiura T, Kakuda Y, Ashida R, Tamura S, Okamura Y, Ito T, Ohgi K, Nakanuma Y, Uesaka K.
    Anticancer Res; 2019 Apr; 39(4):2121-2127. PubMed ID: 30952758
    [Abstract] [Full Text] [Related]

  • 8. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma.
    Lok T, Chen L, Lin F, Wang HL.
    Hum Pathol; 2014 Feb; 45(2):394-400. PubMed ID: 24439226
    [Abstract] [Full Text] [Related]

  • 9. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A, Lipsett PA, Lillemoe KD, Fox-Talbot MK, Coleman J, Cameron JL, Pitt HA.
    Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [Abstract] [Full Text] [Related]

  • 10. Intrahepatic cholangiocarcinoma: new insights in pathology.
    Sempoux C, Jibara G, Ward SC, Fan C, Qin L, Roayaie S, Fiel MI, Schwartz M, Thung SN.
    Semin Liver Dis; 2011 Feb; 31(1):49-60. PubMed ID: 21344350
    [Abstract] [Full Text] [Related]

  • 11. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance.
    Zheng J, Zhu YM.
    Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040
    [Abstract] [Full Text] [Related]

  • 12. Calcium-binding protein S100P is a novel diagnostic marker of cholangiocarcinoma.
    Hamada S, Satoh K, Hirota M, Kanno A, Ishida K, Umino J, Ito H, Kikuta K, Kume K, Masamune A, Katayose Y, Unno M, Shimosegawa T.
    Cancer Sci; 2011 Jan; 102(1):150-6. PubMed ID: 21029254
    [Abstract] [Full Text] [Related]

  • 13. Proposal of progression model for intrahepatic cholangiocarcinoma: clinicopathologic differences between hilar type and peripheral type.
    Aishima S, Kuroda Y, Nishihara Y, Iguchi T, Taguchi K, Taketomi A, Maehara Y, Tsuneyoshi M.
    Am J Surg Pathol; 2007 Jul; 31(7):1059-67. PubMed ID: 17592273
    [Abstract] [Full Text] [Related]

  • 14. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C, Herlea V, Dragnea A, Popescu I.
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [Abstract] [Full Text] [Related]

  • 15. Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts.
    Itatsu K, Zen Y, Yamaguchi J, Ohira S, Ishikawa A, Ikeda H, Sato Y, Harada K, Sasaki M, Sasaki M, Sakamoto H, Nagino M, Nimura Y, Ohta T, Nakanuma Y.
    Hum Pathol; 2008 May; 39(5):710-9. PubMed ID: 18329694
    [Abstract] [Full Text] [Related]

  • 16. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
    Kirimlioğlu H, Türkmen I, Başsüllü N, Dirican A, Karadağ N, Kirimlioğlu V.
    Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
    [Abstract] [Full Text] [Related]

  • 17. An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping.
    Akita M, Sawada R, Komatsu M, Suleman N, Itoh T, Ajiki T, Heaton N, Fukumoto T, Zen Y.
    Hum Pathol; 2021 Mar; 109():45-52. PubMed ID: 33321161
    [Abstract] [Full Text] [Related]

  • 18. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
    Vasuri F, Rocchi L, Degiovanni A, Giunchi F, Brandi G, Treré D, Montanaro L, D'Errico-Grigioni A.
    Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
    [Abstract] [Full Text] [Related]

  • 19. Comparative clinicopathological study of biliary intraductal papillary neoplasms and papillary cholangiocarcinomas.
    Fujikura K, Fukumoto T, Ajiki T, Otani K, Kanzawa M, Akita M, Kido M, Ku Y, Itoh T, Zen Y.
    Histopathology; 2016 Dec; 69(6):950-961. PubMed ID: 27410028
    [Abstract] [Full Text] [Related]

  • 20. Clinicopathological significance of S100 protein expression in cholangiocarcinoma.
    Sato Y, Harada K, Sasaki M, Nakanuma Y.
    J Gastroenterol Hepatol; 2013 Aug; 28(8):1422-9. PubMed ID: 23621473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.